PDHA1 and neoplasm: As a further proof-of-concept of molecular mechanism, the ELISA assay performed in LLC-bearing mice tumor samples revealed a significant inhibition of S232-PDHA1 phosphorylation, confirming PDK as a downstream target of the newly developed 3-amino-1,2,4-triazines.